$4550
$3640
[Research Report] The amniotic products market is expected to grow from US$ 1,164.32 million in 2022 to US$ 1,889.07 million by 2028. It is estimated to grow at a CAGR of 8.4% from 2022 to 2028.
Traumatic wounds are a significant clinical, social, and economic burden because of the rising healthcare expenditures, an aging population, identification of difficult-to-treat infection risks such as biofilms, and the global hazard of diabetes and obesity. Traumatic wounds are those that have not proceeded through the normal healing process and have been open for longer than a month. In comparison to the overall burden of chronic wounds as a health care concern, research funding dedicated to studying chronic wounds is disproportionately low. Wound healing using amniotic membrane grafts has some therapeutic potential. Early use of an amniotic membrane for ulcers, burns, and cutaneous injuries proved therapeutic. Therefore, an increasing number of traumatic wounds is boosting the amniotic product market.
The amniotic products market is analyzed into type, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Amniotic Products Market: Strategic Insights
Market Size Value in US$ 1,164.32 million in 2022 Market Size Value by US$ 1,889.07 million by 2028 Growth rate CAGR of 8.4% from 2022 to 2028. Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Amniotic Products Market: Strategic Insights
Market Size Value in | US$ 1,164.32 million in 2022 |
Market Size Value by | US$ 1,889.07 million by 2028 |
Growth rate | CAGR of 8.4% from 2022 to 2028. |
Forecast Period | 2022-2028 |
Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystLucrative Regions for Amniotic Products Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights - Amniotic Products Market
Rising Incidence of Burn Injuries and Increasing Number of Traumatic Wounds to Drive Amniotic Products Market
According to a 2018 retrospective examination of Medicare users, 8.2 million persons suffered wounds that were infected or not. The cost of acute and chronic wound treatments was estimated to cost between US$ 28.1 billion and US$ 96.8 billion by Medicare. Surgical wounds were the most expensive, followed by diabetic foot ulcers, with the cost of outpatient wound care higher than inpatient wound care. Traumatic wound patients are a significant clinical, social, and economic burden because of the rising healthcare expenditures, an aging population, identification of difficult-to-treat infection risks, such as biofilms, and the global hazard of diabetes and obesity.
Compared to the overall burden of chronic wounds as a health care concern, research funding dedicated to studying chronic wounds is disproportionately low. Wound healing using amniotic membrane grafts has some therapeutic potential. Early use of an amniotic membrane for ulcers, burns, and cutaneous injuries proved therapeutic.
Following are a few examples of companies that launched new products developments and product approvals:
- In June 2021, MiMedx Group, Inc. announced successful regulatory approval from the Japanese Ministry of Health, Labor and Welfare (JMHLW), known to market EPIFIX in Japan. With this approval, the company claims that the geographic expansion will increase revenue and customer bases and ensure the company’s growth.
- In February 2020, AmnioExcel Plus was introduced by Integra LifeSciences Holdings Corporation. It is a novel technology that physicians can use in both the operating room and ambulatory wound care setting to help end the epidemic of approximately 8.2 million wounds with an estimated annual cost to Medicare of up to $98.6 billion fight.
Such product developments by market players are driving the amniotic products market.
Type-Based Insights - Amniotic Products Market
Based on type, the amniotic products market has been bifurcated into amniotic membranes and amniotic suspensions. The amniotic membranes segment is likely to hold the largest share of the market in 2022. The amniotic membrane segment growth is growing due to increasing research in stem cell and regenerative medicine, high R&D investments, and an increase in the number of surgeries conducted globally. Further, they are commonly employed in the treatment of bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, corneal degeneration, ocular dystrophy, eyelid reconstruction, and other eye surface problems. The expansion in the world's senior population increases the number of ophthalmology surgeries, , resulting in a growing need for tissue-based products.
Amniotic Products Market, by Type – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Services-Based Insights
Based on application, the global amniotic products market is segmented into wound care, orthopedics, ophthalmology, and other applications. Wound care is a challenging and constantly changing field of medicine. Chronic wounds, in particular, occupy a significant amount of time, effort, and money in the medical community. Due to various factors, including neuropathy, hyperglycemia, infection, and other concurrent disorders, the wounds are more likely to develop chronic.
The human amniotic membrane has been used for nearly a century to treat wounds. Since the early twentieth century, amniotic membrane allografts (AMAs) have been used to treat burns, ulcers, traumatic wounds, surgical incisions, and ocular problems in various medical disciplines. The use of AMAs in treating chronic ulcers is one area where they have acquired a lot of traction. As new preservation techniques and research advances, AMAs have been highly employed in the medical community, particularly in offices and wound care centers. This has also expanded the usage of allografts among physicians who practice non-surgical specialties.
Furthermore, the increasing number of traumatic injuries globally propel the wound care segment. For instance, as per WHO, around 1,000,000 people are severely or moderately burnt annually in India. In addition, as per NCBI, every day, over 30,000 people suffer new burns worldwide, severe enough to warrant medical attention, equating to an estimated 11 million new burns each year globally.
Partnerships and collaborations are highly adopted strategies by the global amniotic products market players. A few of the recent key market developments are listed below:
In June 2021, MiMedx Group, Inc. announced the publication of its peer-reviewed study in the Journal of Investigative Dermatology (JID) Innovations, addressing the potential utility of MiMedx Purion-processed human amniotic/chorionic membrane (dHACM) dehydrated in combating complications of excessive fibrosis, a pathological process central to a number of serious unmet medical needs. It is estimated that more than 100 million people worldwide suffer from pathological scarring each year, including hypertrophic and keloid scarring, with long-term effects ranging in severity from minor cosmetic defects to significantly compromised tissue architecture and dysfunction in a range of conditions. Product development and innovation will strengthen the product portfolio in the near future.
Due to widespread lockdowns, denied wound care services, and cancelled or postponed elective surgeries, the COVID-19 outbreak had a negative impact on the amniotic products market in 2020. Elective procedures were denied (cancelled/postponed) in order to allocate or redirect scarce capacities and resources (such as hospital beds and patient care professionals) to COVID-19 patient care. In addition, to combat the increased number of COVID-19 cases, several countries imposed lockdowns and curfews. Patients were unable to visit hospitals, outpatient clinics, or clinics due to the lockdowns. The amniotic products industry is projected to be limited by this temporary suspension of non-emergent healthcare services. However, in the next years, demand for amniotic products is projected to increase.
Amniotic Products Market Segmentation
The global amniotic products market is analyzed on the basis of type, application, end user, and geography. In terms of type, the market is bifurcated into amniotic membranes and amniotic suspensions. Based on application, the market is segmented into wound care, orthopedics, ophthalmology, and other applications. Based on end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. Geographically, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Company Profiles
- MiMedx
- Smith & Nephew
- Integra LifeSciences
- Stryker
- Organogenesis
- Katena Products, Inc.
- NuVision Biotherapies Ltd
- Lucina BioSciences
- Next Biosciences
- Sanuwave and Sanuwave Health, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global amniotic products market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2022, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 8.8% during the forecast period
The global amniotic products market based on type, is segmented into amniotic membranes, and amniotic suspensions. In 2022, amniotic membranes segment held largest market share and the segment is estimated to grow at the fastest CAGR of 8.9% during the forecast period.
The amniotic products market majorly consists of the players such as MiMedx; Smith & Nephew; Integra Lifesciences; Stryker.; Organogenesis, Inc.; Katena Products, Inc.; NuVision Biotherapies Ltd., Lucina Biosciences.; and Next Biosciences.
Factors such as the rising incidence of burn injuries and increasing number of traumatic wounds.
The complications and limitations associated with the use of amniotic membranes is expected to restrict the market growth during the forecast period
Amniotic products are the amniotic tissues and their parts that are used to provide protection and support for the injured tissue and other body parts. The amniotic membrane and suspension are two products that can be used for treatment. The amniotic membrane is the innermost layer of the placenta that nourishes and maintains an unborn child. Amniotic fluid is the liquid that surrounds the baby until delivery.
The List of Companies - Amniotic Products Market
- MiMedx
- Smith & Nephew
- Integra LifeSciences
- Stryker
- Organogenesis
- Katena Products, Inc.
- NuVision Biotherapies Ltd.
- Lucina BioSciences
- Next Biosciences
- Sanuwave and Sanuwave Health, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Amniotic Products Market
Jun 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2022
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)